Acetylcholinesterase interaction with Alzheimer amyloid beta

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Acetylcholinesterase (AChE) is crucial for nervous system functions.
• AChE associated with senile plaques exhibits distinct enzymatic properties compared to neuronal AChE.
• AChE interacts with amyloid-beta (Abeta) to form toxic complexes.

Purpose of the Study:

• To investigate the role of Acetylcholinesterase in Alzheimer's disease pathogenesis.
• To explore the mechanism by which AChE influences amyloid formation and neurotoxicity.
• To evaluate the potential of targeting AChE for Alzheimer's disease treatment.

Main Methods:

• Biochemical assays to study AChE-Abeta interactions and amyloid fibril formation.
• In vitro studies using hippocampal neurons to assess neurotoxicity.
• In vivo studies in a rat model of Alzheimer's disease.

Main Results:

• AChE induces amyloid fibril formation and generates highly toxic AChE-Abeta complexes.
• A peptide mimicking the enzyme's peripheral binding site (PAS) replicates AChE's effect on amyloid formation.
• AChE-Abeta complexes induce greater neurodegeneration than Abeta alone in vitro and in vivo.
• The amyloid-promoting effect of AChE is sensitive to drugs blocking its PAS.

Conclusions:

• AChE plays a significant role in accelerating amyloid formation and neurodegeneration in Alzheimer's disease.
• The peripheral binding site (PAS) of AChE is critical for its pro-amyloidogenic activity.
• Developing specific AChE inhibitors targeting the PAS presents a promising therapeutic avenue for Alzheimer's disease.